A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. With this mda-9 mice model, Fisher and his team observed how ...

BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...

RK-33 also showed promise in preventing breast cancer bone metastasis from occurring in the first place. Mice with breast cancer that had not spread to bone received the drug, and researchers observed ...

Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Researchers have developed a new therapeutic strategy of combining two existing medications to inhibit bone metastasis and improve survival in breast cancer patients. They used both an animal model ...

Breast Cancer Now and Prostate Cancer Research have joined forces to fund up to £600,000 of new research to tackle the spread of both cancers to the bones, known as bone metastasis. Nearly all types ...

For patients under 55 years old: Papillary thyroid cancer is classified as stage 2 if the cancer has spread to distant parts ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...